Renal Function Tests Market - Introduction
Kidneys are among the most vital organs of the human body. Kidneys act as blood filters, reabsorbing the essential elements and removing the water-soluble waste products from the blood. Since kidneys play such an important role, these require constant regeneration of dead nephrons and proper blood circulation to maintain healthy cell growth.
Functional damage of kidneys is common across the world, and its incidence is increasing globally. High blood pressure, hypertension, diabetes, excessive alcohol consumption, frequent urges to urinate, blood in urine, difficulty in urination, and puffiness in the hands and feet due to buildup of fluids in the body are the major symptoms and causative factors of chronic kidney disease. Renal function tests measure the amount of certain substances released into the blood or urine by the kidneys. The kidney function tests are performed to identify the renal disease to determine appropriate patient management and prevent further deterioration of renal function.
Renal Function Tests Market – Competitive Landscape
- In October 2018, Siemens Healthineers AG entered an original equipment manufacturer (OEM) alliance with Israel-based Healthy.io Company. The alliance aimed at integration of urinalyses reagents of former company into smartphone-based urinalysis system of Healthy.io. To provide patients with increased access to home based urinalysis testing for detection of chronic kidney disease.
- Siemens Healthineers formed a strategic alliance with the National Kidney Foundation and to offer no-cost urine testing to patients with high risk of kidney disease in the U.S. This is anticipated to improve the diagnosis and treatment of kidney disease and strengthen its geographic presence.
Identify the key factors that will drive your company’s growth, Request a brochure of this report here
Siemens Healthineers AG
Founded in 1847, Siemens Healthineers AG is a global provider of health care solutions and services. The company develops, manufactures, and sells a diverse range of market-leading and innovative diagnostic, imaging, and advanced therapy products and services to healthcare providers around the world. The company focuses on investment in R&D to develop products for the effective treatment of renal disorders as well as engage in strategic collaborations to create awareness and foster adoption of kidney function tests.
- Hoffmann-La Roche
Incorporated in 1896, F. Hoffmann-La Roche is based in Basel, Switzerland. F. Hoffmann-La Roche Ltd. is a prominent biotechnology company that develops and markets breakthrough medicines and diagnostic solutions across various medical specialties. The company operates through two major divisions: pharmaceutical and diagnostics. The company offers diverse products and solutions in the fields of clinical chemistry & immunoassay, molecular diagnostics, tissue diagnostics, point-of-care diagnostics, and hematology and hemostasis. It provides various test kits such as Chemstrip test or Combur-Test for the detection of albumin in urine for early diagnosis of chronic kidney disease.
Other prominent players operating in the global renal function tests market are Sysmex Corporation, OPTI Medical, Beckman Coulter, ARKRAY, Nova Biomedical, 77 Elektronika, Abbott, Metabolic Solutions Development Company, LLC, IDEXX Laboratories, URIT Medical, Randox Laboratories, and Otsuka Holdings Co., Ltd., among others.
Renal Function Tests Market - Dynamics
Rise in Incidence of Chronic Kidney Disease Globally Drives Market
Increase in incidence of chronic kidney diseases (CKD) across the globe is a major factor driving the global renal function tests market. For instance, 1 in 4 men and 1 in 5 women aged 65 years and above suffer from chronic kidney disease across the globe. Currently, 10% to 15% of the global population is affected with chronic kidney disease. According to the World Health Organization, each year, more than 1.4 million people across the world undergo kidney replacement therapy, with the incidence rate of chronic kidney disease increasing by nearly 8% annually. Moreover, according to Kidney Care UK, currently, 3 million people are affected by chronic kidney disease in the U.K. All these factors are anticipated to boost the demand for renal function tests in the near future.
Expanding operations in future? To get the perfect launch ask for a custom report here
Growing Prevalence of Diabetes Propels Renal Function Tests Market
Hypertension and diabetes are the most common causes of chronic kidney disease. According to National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), 1 in 4 adults suffering from diabetes have chronic kidney disease. Based on National Kidney Foundation, approximately 35% of people aged 20 years and above living with diabetes have chronic kidney disease. Additionally, diabetes led to more than 51,000 new cases of kidney failure in 2013 in the U.S. Hence, rise in prevalence of diabetes and increase in elderly patient pool are the other major factors likely to boost demand for renal function tests during the forecast period. However, high cost of treatment and complications including exposure to radiation during glomerular filtration rate tests are likely to restrain the market during the forecast period.
North America Dominates the Renal Function Tests Market while Asia Pacific to Provide Lucrative Growth Opportunities
North America is projected to account for dominant share of the global market between 2019 and 2027. This is attributed to rise in prevalence of chronic kidney disease and favorable government support for early diagnosis and treatment in the U.S. For instance, 1 in 3 adults in the U.S. is at high risk of developing chronic kidney disease. This is attributed to various factors such as high blood pressure, diabetes, family history of kidney failure, and high geriatric population aged 60 years and above.
The renal replacement market in Asia Pacific is expected to grow at a rapid pace owing to adoption of western and sedentary lifestyle, increase in incidence of diabetes, rise in baby boomer population, and excessive alcohol consumption in emerging countries such as India and China.
Renal Function Tests Market – Segmentation
The renal function tests market can be segmented based on:
Renal Function Tests Market Segmentation – By Type
In terms of type, the renal function tests can be categorized into:
- Urine Tests
- Urine Protein Test
- Creatinine Clearance Test
- Micro Albumin Test
- Blood tests
- Glomerular Filtration Rate Tests
- Blood Urea Nitrogen Test (BUN test)
- Serum Creatinine Tests
- Imaging tests
Renal Function Tests Market Segmentation – Bye End-user
Based on end-user, the global renal function tests market can be divided into:
- Diagnostic Laboratories
- Research Labs & Institutes
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.